Detalles de la búsqueda
1.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Lancet Oncol;
25(5): 572-587, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561010
2.
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.
Lancet Oncol;
24(4): 335-346, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36898391
3.
How to prevent human papillomavirus-related oropharyngeal cancer?
Curr Opin Oncol;
35(3): 145-150, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36966500
4.
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic.
Lancet Oncol;
23(12): e544-e551, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36455583
5.
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.
Lancet Oncol;
23(7): 865-875, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35660139
6.
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA.
Future Oncol;
2022 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36200668
7.
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol;
22(4): 463-475, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33684370
8.
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Lancet;
394(10212): 1915-1928, 2019 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31679945
9.
A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment.
Invest New Drugs;
38(6): 1774-1783, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32410080
10.
The emergence of long-term survivors in recurrent and metastatic squamous cell head and neck cancer.
Curr Opin Oncol;
31(3): 160-168, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30844888
11.
Opioid-Induced Constipation in Oncological Patients: New Strategies of Management.
Curr Treat Options Oncol;
20(12): 91, 2019 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31853656
12.
Translational Research Opportunities Regarding Homologous Recombination in Ovarian Cancer.
Int J Mol Sci;
19(10)2018 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30347758
13.
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
Lancet Oncol;
18(3): 323-335, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28131786
14.
p16, HPV, and Cetuximab: What Is the Evidence?
Oncologist;
22(7): 811-822, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28526718
15.
Unresolved questions regarding the promise of the TPEx regimen - Authors' reply.
Lancet Oncol;
22(6): e228-e229, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34087138
16.
Enrichment of Cells with Cancer Stem Cell-Like Markers in Relapses of Chemoresistant Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma.
Oncology;
90(5): 267-72, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27077749
17.
Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.
Lancet Oncol;
16(2): 221-32, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25596659
18.
Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial.
Lancet Oncol;
16(2): 208-20, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25596660
19.
Real-world treatment outcomes of immune checkpoint inhibitors used off-label in oncology: A comprehensive cancer institution experience.
Pharmacol Res Perspect;
12(1): e1167, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38193611
20.
HLA-I levels correlate with survival outcomes in response to immune checkpoint inhibitors in non-small cell lung cancer.
Lung Cancer;
189: 107502, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38359742